| Remission/low disease activitya | Moderate-to-high disease activitya | ||||
---|---|---|---|---|---|---|
Measure | Concordant group (n = 10) | Discordant group (n = 28) | P value | Concordant group (n = 10) | Discordant group (n = 18) | P value |
Pain VAS | 18.5 (3.0–26.0) | 37.0 (24.0–56.0) | .006 | 36.0 (14.0–50.0) | 66.0 (56.0–74.0) | .02 |
HAQ-II | 0.2 (0.0–0.3) | 0.9 (0.5–1.2) | .001 | 0.9 (0.4–1.2) | 1.2 (0.7–1.2) | .10 |
SF-MPQ-2 | 0.7 (0.3–1.6) | 1.4 (0.8–2.6) | .10 | 1.9 (1.0–2.7) | 2.3 (1.8–3.9) | .18 |
WPI | 5.0 (1.0–8.0) | 6.0 (4.0–9.0) | .18 | 4.0 (3.0–7.0) | 8.0 (6.0–10.0) | .005 |
SS score | 2.5 (1.0–4.0) | 4.0 (3.0–6.0) | .11 | 4.0 (2.0–6.0) | 6.0 (3.0–8.0) | .16 |
PSD | 8.0 (2.0–12.0) | 9.0 (8.0–15.0) | .13 | 7.5 (6.0–13.0) | 13.5 (10.0–16.0) | .01 |
BRAF score | 4.5 (3.7–5.3) | 5.2 (4.3–6.3) | .23 | 5.0 (4.0–6.0) | 6.3 (4.3–7.0) | .28 |
PROMIS | ||||||
 Pain interference | 1.3 (1.1–1.8) | 1.9 (1.5–2.4) | .05 | 2.2 (1.6–2.8) | 2.9 (2.1–3.5) | .05 |
 Ability to participate | 4.3 (3.8–5.0) | 3.5 (3.1–4.2) | .02 | 3.7 (3.1–4.0) | 3.3 (2.6–4.0) | .43 |
 Sleep disturbance | 1.6 (1.3–2.3) | 2.1 (1.8–2.9) | .06 | 2.3 (1.9–2.8) | 2.5 (1.8–3.3) | .50 |
 Fatigue | 1.8 (1.0–3.4) | 2.6 (2.0–3.5) | .10 | 2.9 (2.3–3.4) | 3.1 (2.3–3.8) | .43 |
MAAS | 5.0 (4.5–5.6) | 5.1 (4.6–5.4) | .95 | 4.4 (4.1–4.9) | 5.3 (4.5–5.5) | .07 |
PHQ-9 | 1.0 (0.0–5.0) | 4.0 (2.0–6.0) | .04 | 4.0 (2.0–11.0) | 4.0 (3.0–6.0) | >.99 |
GAD-7 | 0.0 (0.0–1.0) | 1.0 (0.0–3.0) | .06 | 1.5 (0.0–4.0) | 1.5 (1.0–6.0) | .71 |